Takao Hashiguchi

Prof. Takao Hashiguchi

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
TTTomokazu Tamura
Tomokazu Tamura
JIJumpei Ito
Jumpei Ito
KUKeiya Uriu
Keiya Uriu
JZJiri Zahradnik
Jiri Zahradnik
IKIzumi Kida
Izumi Kida
TUTakamasa Ueno
Takamasa Ueno
In late 2022, SARS-CoV-2 Omicron subvariants have become highly diversified, and XBB is spreading rapidly around the world. Our phylogenetic analyses suggested that XBB emerged through the recombination of two cocirculating BA.2 lineages, BJ.1 and BM.1.1.1 (a progeny of BA.2.75), during the summer of 2022. XBB.1 is the variant most profoundly resistant to BA.2/5 breakthrough infection sera to date and is more fusogenic than BA.2.75. The recombination breakpoint is located in the receptor-binding domain of spike, and each region of the recombinant spike confers immune evasion and increases fusogenicity. We further provide the structural basis for the interaction between XBB.1 spike and human ACE2. Finally, the intrinsic pathogenicity of XBB.1 in male hamsters is comparable to or even lower than that of BA.2.75. Our multiscale investigation provides evidence suggesting that XBB is the first observed SARS-CoV-2 variant to increase its fitness through recombination rather than substitutions.

9 January 2011 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
THTakao Hashiguchi
Takao Hashiguchi
TOToyoyuki Ose
Toyoyuki Ose
MKMarie Kubota
Marie Kubota
NMNobuo Maita
Nobuo Maita
JKJun Kamishikiryo
Jun Kamishikiryo
YYYusuke Yanagi
Yusuke Yanagi

4 December 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
THTakao Hashiguchi
Takao Hashiguchi
MKMizuho Kajikawa
Mizuho Kajikawa
NMNobuo Maita
Nobuo Maita
Makoto TakedaMakoto Takeda
Makoto Takeda
KKKimiko Kuroki
Kimiko Kuroki
KMKatsumi Maenaka
Katsumi Maenaka
Measles still remains a major cause of childhood morbidity and mortality worldwide. Measles virus (MV) vaccines are highly successful, but the mechanism underlying their efficacy has been unclear. Here we report the crystal structure of the MV attachment protein, hemagglutinin, responsible for MV entry. The receptor-binding head domain exhibits a cubic-shaped β-propeller structure and forms a homodimer. N-linked sugars appear to mask the broad regions and cause the two molecules forming the dimer to tilt oppositely toward the horizontal plane. Accordingly, residues of the putative receptor-binding site, highly conserved among MV strains, are strategically positioned in the unshielded area of the protein. These conserved residues also serve as epitopes for neutralizing antibodies, ensuring the serological monotype, a basis for effective MV vaccines. Our findings suggest that sugar moieties in the MV hemagglutinin critically modulate virus–receptor interaction as well as antiviral antibody responses, differently from sugars of the HIV gp120, which allow for immune evasion.

11 May 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
JIJumpei Ito
Jumpei Ito
RSRigel Suzuki
Rigel Suzuki
KUKeiya Uriu
Keiya Uriu
YIYukari Itakura
Yukari Itakura
JZJiri Zahradnik
Jiri Zahradnik
KSKei Sato
Kei Sato
In late 2022, various Omicron subvariants emerged and cocirculated worldwide. These variants convergently acquired amino acid substitutions at critical residues in the spike protein, including residues R346, K444, L452, N460, and F486. Here, we characterize the convergent evolution of Omicron subvariants and the properties of one recent lineage of concern, BQ.1.1. Our phylogenetic analysis suggests that these five substitutions are recurrently acquired, particularly in younger Omicron lineages. Epidemic dynamics modelling suggests that the five substitutions increase viral fitness, and a large proportion of the fitness variation within Omicron lineages can be explained by these substitutions. Compared to BA.5, BQ.1.1 evades breakthrough BA.2 and BA.5 infection sera more efficiently, as demonstrated by neutralization assays. The pathogenicity of BQ.1.1 in hamsters is lower than that of BA.5. Our multiscale investigations illuminate the evolutionary rules governing the convergent evolution for known Omicron lineages as of 2022.

1 February 2015 in Cell
Verified
Journal Article
Closed access
AFAndrew I. Flyak
Andrew I. Flyak
PIPhilipp A. Ilinykh
Philipp A. Ilinykh
CMCharles D. Murin
Charles D. Murin
TGTania Garron
Tania Garron
XSXiaoli Shen
Xiaoli Shen
JCJames E. Crowe
James E. Crowe

1 February 2015 in Cell
Verified
Journal Article
Closed access
THTakao Hashiguchi
Takao Hashiguchi
MFMarnie L. Fusco
Marnie L. Fusco
ZBZachary A. Bornholdt
Zachary A. Bornholdt
JLJeffrey E. Lee
Jeffrey E. Lee
AFAndrew I. Flyak
Andrew I. Flyak
ESErica Ollmann Saphire
Erica Ollmann Saphire